Xyz risk factors: Difference between revisions

Jump to navigation Jump to search
Line 2: Line 2:
{{Xyz}}
{{Xyz}}


{{CMG}}; {{AE}}  
{{AE}}  
==Overview==
==Overview==
There are no established risk factors for [disease name].
There are no established risk factors for [disease name].
Line 19: Line 19:


==Risk Factors==
==Risk Factors==
There are no established risk factors for [disease name].
Common risk factors in the development of [[monoclonal gammopathy of undetermined significance]] include serum monoclonal protein level ≥1.5 g/dL.
 
===Common Risk Factors===
OR
* Serum monoclonal protein level ≥1.5 g/dL [9,29-31]
 
The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].


OR
* Non-IgG MGUS (ie, IgA, IgM, IgD MGUS)
 
* Abnormal serum free light chain ratio (ie, ratio of kappa to lambda free light chains <0.26 or >1.65) [32,34]
Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
* The absolute risk of disease progression over 20 years for patients with various combinations of risk factors is [32,33]:
===Common Risk Factors===
* 3 risk factors (high-risk MGUS) – 58 percent
*Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.
* 2 risk factors (high-intermediate risk MGUS) – 37 percent
*Common risk factors in the development of [disease name] include:
* 1 risk factor (low-intermediate risk MGUS) – 21 percent
**[Risk factor 1]
* No risk factors (low-risk MGUS) – 5 percent
**[Risk factor 2]
**[Risk factor 3]


===Less Common Risk Factors===
**
*Less common risk factors in the development of [disease name] include:
**[Risk factor 1]
**[Risk factor 2]
**[Risk factor 3]


==References==
==References==

Revision as of 16:38, 7 August 2018

Xyz Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Xyz from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Xyz risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Xyz risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Xyz risk factors

CDC on Xyz risk factors

Xyz risk factors in the news

Blogs on Xyz risk factors

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Xyz risk factors

Associate Editor(s)-in-Chief:

Overview

There are no established risk factors for [disease name].

OR

The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].

OR

Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

OR

Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.

Risk Factors

Common risk factors in the development of monoclonal gammopathy of undetermined significance include serum monoclonal protein level ≥1.5 g/dL.

Common Risk Factors

  • Serum monoclonal protein level ≥1.5 g/dL [9,29-31]
  • Non-IgG MGUS (ie, IgA, IgM, IgD MGUS)
  • Abnormal serum free light chain ratio (ie, ratio of kappa to lambda free light chains <0.26 or >1.65) [32,34]
  • The absolute risk of disease progression over 20 years for patients with various combinations of risk factors is [32,33]:
  • 3 risk factors (high-risk MGUS) – 58 percent
  • 2 risk factors (high-intermediate risk MGUS) – 37 percent
  • 1 risk factor (low-intermediate risk MGUS) – 21 percent
  • No risk factors (low-risk MGUS) – 5 percent

References

Template:WH Template:WS